Philip R Schauer
Overview
Explore the profile of Philip R Schauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
248
Citations
10012
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Megison H, Corpodean F, Danos D, Kachmar M, Cook M, Schauer P, et al.
J Surg Res
. 2025 Feb;
305:231-236.
PMID: 39937555
Introduction: Operative selection in metabolic surgery is a complex, collaborative process between patient and surgeon, considering factors such as risk, cost, desired weight loss, and resolution of associated comorbidities. This...
2.
Simonson D, Gourash W, Arterburn D, Hu B, Kashyap S, Cummings D, et al.
Diabetes Care
. 2025 Feb;
PMID: 39903478
Objective: Type 2 diabetes and obesity are associated with reduced health-related quality of life (HRQoL) and health utility (HU), but long-term effects of metabolic/bariatric surgery (MBS) compared with those of...
3.
Kachmar M, Doiron J, Corpodean F, Danos D, Cook M, Schauer P, et al.
Obes Surg
. 2025 Jan;
35(3):915-925.
PMID: 39883396
Introduction: Metabolic and bariatric surgery (MBS) is increasingly used for obesity and metabolic disease, with safety profiles showing it is among the safest major operations. The last 20 + years...
4.
Rubino F, Cummings D, Eckel R, Cohen R, Wilding J, Brown W, et al.
Lancet Diabetes Endocrinol
. 2025 Jan;
13(3):221-262.
PMID: 39824205
No abstract available.
5.
Schauer P, Rothberg A
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39693237
Obesity is a chronic, relapsing condition with severe health risks and a huge economic burden. Effective interventions for severe obesity include bariatric or metabolic surgery and high-intensity medical management involving...
6.
Axelrod C, Hari A, Dantas W, Kashyap S, Schauer P, Kirwan J
Diabetes Care
. 2024 Sep;
47(11):2024-2032.
PMID: 39311919
Objective: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are effective procedures to treat and manage type 2 diabetes (T2D). However, the underlying metabolic adaptations that mediate improvements in glucose...
7.
Ikizler T, Kramer H, Beddhu S, Chang A, Friedman A, Harhay M, et al.
J Am Soc Nephrol
. 2024 Sep;
35(11):1574-1588.
PMID: 39292519
No abstract available.
8.
Lundholm M, Kirschling S, Hu B, Aminian A, Arterburn D, Courcoulas A, et al.
Diabetes Obes Metab
. 2024 Sep;
26(12):6055-6061.
PMID: 39267261
No abstract available.
9.
Schauer T, Kachmar M, Corpodean F, Belmont K, Danos D, Cook M, et al.
Surg Obes Relat Dis
. 2024 Aug;
20(12):1216-1224.
PMID: 39153899
Background: Early small bowel obstruction (eSBO) (within 30-days) is a rare but important complication that is associated with high rates of morbidity, including readmission, reintervention, and reoperation. Objectives: To identify...
10.
Ducote M, Schauer T, Ross R, Boyer L, Stagg M, Domangue E, et al.
Surg Obes Relat Dis
. 2024 Aug;
20(11):1172-1178.
PMID: 39129110
Background: Endometrial cancer (EC) is the strongest obesity-associated malignancy and the fastest-growing cancer in young women. Early identification of EC and other endometrial pathology (malignant and nonmalignant) in women with...